5 High-Multiple Stocks Loved by Hedge Funds

We have identified five stocks that might be scary to some investors, but are loved by hedge funds. These stocks trade at P/E ratios that seems darn right ridiculous, especially when compared to their industry averages.

We found five stocks that are trading at ridiculously high price-to-earnings ratios, yet have a huge following of billionaire fund managers that continue to load up. All companies discussed here are expected to grow EPS by at least 15% over the next five years.

FISHER ASSET MANAGEMENT

Whole Foods Market Inc. (NYSE:WFM) is the first company on our list, trading at a P/E ratio of 41x. Whole Foods is considered the largest organic food retailer in North America and saw 3Q EPS that beat consensus estimates of $0.61, by posting $0.63. As well, the company continues to offer a variety of items across various departments and has shown an 8.8% increase in comparable sales in the first three quarters of 2012. Some of the best growth prospects in the grocery industry have Whole Foods expected to expand annual EPS by 17% over the next five years.

Columbus Circle Investors was the top fund invested in 2Q, owning over 1.6 million shares. Jim Simons upped his 1Q stake by 60%, while Ken Fisher took an entirely new stake in the company—see how hedge funds are trading grocers.

Another stock with high fund interest is Facebook Inc (NASDAQ:FB). The social network trades at 106x earnings and expected to grow EPS at 27% annually over the next five years. Facebook investors were beginning to question user engagement and mobile monetization capabilities, but Facebook knocked earnings out of the park for its most recent quarter, and may have possibly figured out advertising. The company is expected to grow revenue 28% in 2013 and 25% in 2014. Facebook saw two tiger cubs as the top two fund owners. Both funds owned over 1.5 million shares, as well as JAT Capital.

Visa Inc (NYSE:V) trades at a P/E of 138x and is expected to grow at an annual growth rate of 20% over the next five years. Visa is expected to grow operating revenues 13% in 2012, after a 14% increase in 2011. Driving revenues will be increase in payment volumes internationally. As well, banks are gearing more toward credit cards, versus debit cards, expanding Visa’s margins overall.

Visa had some of the top fund interest of all our high P/E stocks. Most notably was Warren Buffett, with over 2 million shares in 2Q. Other notables included Ken Griffin and Tiger Global Management, as well as Ken Fisher, who upped his stake 175,000%.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) develops antibody therapeutics for rare and severe diseases. The company is still up over 30% year to date, but has fallen on rough times over the past week and is down 18% over the last few days. Alexion is trading at a P/E of 107x, but is expected to grow at a 5-year CAGR of 38%. Alexion’s key drug, Soliris, is expected to see sales up 40% in 2012, and 30% in 2103. Soliris is Alexion’s rare blood disorder drug. As well, gross margins are expected to be 88% for both years.

Albeit a biopharma stock, there was much 2Q fund interest. Jim Simons increased his stake 200% to over 1 million shares. As well, Arrowstreet Capital upped their stake over 1000%. Alexion remains to be a top pick of Navellier & Associates.

Amazon.com Inc. (NASDAQ:AMZN) trades at a P/E of nearly 300x and sales are expected to be up 28% in 2013, following a 31% increase in 2012. Amazon is expected to continue its onslaught of market share infringement on retailers, as well as continue expansion in the hardware business with its Kindle tablets. These various initiatives and projects are expected to grow EPS at 34% over the next five years.

Amazon saw big interest from its top three names including Ken Fisher, John Griffin and Steven Cohen. Fisher and Griffin kept their stakes stable at over 1.7 million shares, while Cohen and SAC Capital boosted their 1Q stake by 240%.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!